Mead Johnson Nutriti
MJN
Delayed Nyse - 04/21 10:02:05 pm
88.76USD
-0.02%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 7433 650
Operating income (EBITDA)1 026971
Operating profit (EBIT)927866
Pre-Tax Profit (EBT)--
Net income545587
EPS ( $ )2,923,18
Dividend per Share ( $ )1,651,70
Yield2,33%1,91%
Announcement Date01/26/2017
12:30pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt1 1851 026
Finance--
Operating income (EBITDA)1 026971
Leverage
(Debt/EBITDA)
1,15x1,06x
Capital Expenditure149154
Book Value Per Share (BVPS)-2,80 $-2,46 $
Cash Flow per Share3,72 $3,71 $
Announcement Date01/26/2017
12:30pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 16 293 M$ -
Entreprise Value (EV) 17 319 M$ 17 270 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 27,9x 26,0x
Capitalization / Revenue 4,46x 4,34x
EV / Revenue 4,75x 4,60x
EV / EBITDA 17,8x 16,9x
Yield (DPS / Price) 1,91% 2,04%
Price to book (Price / BVPS) -36,1x -45,6x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 23,7% 24,3%
operating Leverage (Delta EBIT / Delta Sales) -2,64x 1,89x
Net Margin (Net Profit / Revenue) 16,1% 16,5%
ROA (Net Profit / Asset) 16,4% 17,0%
ROE (Net Profit / Equities) -122% -124%
Rate of Dividend 53,4% 53,1%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,21% 4,20%
Cash Flow / Sales 18,6% 19,1%
Capital Intensity (Assets / Sales) 0,98x 0,97x
Financial Leverage (Net Debt / EBITDA) 1,06x 0,96x
Price Earning Ratio
BNA & Dividende